DLK2 Activators
DLK2 Activators encompass a suite of chemical compounds that facilitate the enhancement of DLK2's functional activity by specifically influencing signaling pathways and biological processes. Forskolin, through the elevation of cAMP, indirectly enhances DLK2's role by activating PKA, which then phosphorylates substrates within DLK2-related signaling pathways, leading to increased functional activity. Ionomycin's role in raising intracellular calcium promotes activation of kinases and phosphatases that can positively influence DLK2's signaling mechanisms in differentiation. The direct activation of PKC by PMA has implications for proteins within the DLK2 pathway, enhancing DLK2's role in proliferation. Similarly, Isoproterenol elevates cAMP to stimulate pathways that could enhance DLK2 activity, while Retinoic acid directly influences gene expression, affecting DLK2's mediation in cellular differentiation.
In addition to these, Lithium chloride's inhibition of GSK-3 can lead to augmented DLK2 signaling related to cellular processes. The kinase-inhibitory action of EGCG could also contribute to the enhancement of DLK2 activity by impacting relevant pathways. Analogously, db-cAMP, as a cAMP mimic, activates PKA and influences DLK2-associated pathways, boosting DLK2's activity. Okadaic acid, by restraining protein phosphatases, leads to an increase in phosphorylated proteins within DLK2's network, which enhances DLK2's signaling.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which in turn activates PKA. PKA phosphorylates target proteins that can enhance the signaling pathways in which DLK2 is involved, leading to its increased functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent kinases and phosphatases that can enhance DLK2 signaling functions related to cellular differentiation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and alter the function of proteins within the DLK2-associated pathways, enhancing its activity related to cellular proliferation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, leads to the activation of adenylate cyclase and subsequent increase in cAMP, which can enhance DLK2 activity by activating cAMP-dependent pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression via the retinoic acid receptor, impacting differentiation pathways where DLK2 is a critical mediator, thereby enhancing its functional role. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain kinases, potentially affecting pathways that converge on DLK2 signaling, resulting in an enhanced functional activity of DLK2 in cellular differentiation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA, enhancing downstream signaling pathways that DLK2 is involved in, thus potentially increasing DLK2 functional activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of proteins within DLK2’s signaling network, thus enhancing DLK2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters signaling pathways, including those associated with DLK2, potentially leading to an enhancement of DLK2's functional activity in cell signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which may lead to compensatory mechanisms in signaling pathways involving DLK2, thereby enhancing its activity indirectly. | ||||||